Tuesday 13 April 2021 7:30 - 8:30 pm
Depression is one of the leading causes of disability in the world. Current treatments for depression are hampered by only limited effectiveness and slow onset of response. Recently new therapies have emerged that have shown promise for many patients who suffer from this disorder. Some of these therapies include transcranial magnetic stimulation, ketamine and psychedelics for depression and various types of talking and exercise therapy. Science is only just beginning to understand how some of these therapies can be combined for optimal patient outcomes.
Suresh completed his PhD in psychology at the University of Auckland in 2005 after which he joined the newly established Cardiff University Brain Research Imaging Centre as a post-doctoral fellow. In 2014 Suresh received a Rutherford Discovery Fellowship and has returned to Auckland where he works in The School of Pharmacy (Faculty of Medicine and Health Sciences). Suresh’s main research interests are in understanding how therapies alter brain activity and in developing methodologies to measure these changes in both healthy individuals and patient groups. His previous studies have involved a range of compounds including the hallucinogens ketamine, LSD, psilocybin.
Please register for this talk so we can plan seating for the expected numbers. A small donation on arrival at the door is appreciated.